Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neutralizing Antibody Immobilizes West Nile Fever Virus Shell Proteins

By LabMedica International staff writers
Posted on 17 Nov 2010
Recently obtained cryoelectron microscope data has revealed how a human antibody binds to and neutralizes the virus that causes West Nile fever.

Investigators at Purdue University (West Lafayette, IN, USA) worked with the human monoclonal antibody CR4354, which had originally been obtained from a West Nile fever patient. More...
They prepared pure FAB (antigen binding fragment) segments from the antibody and used these peptides in conjunction with cryoelectron microscopy and X-ray crystallography to study the interaction of the antibody with the West Nile virus.

Results published in the November 2, 2010, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) revealed that each FAB segment attached to two adjacent protein molecules that comprise the outer shell of the virus. This cross-linking pattern was repeated over the entire viral shell, interlocking the 30 molecular "rafts” that make up the shell and preventing the structural changes needed for the virus to infect host cells.

"The antibody cross linking causes the virus to become rigid, and this rigidity prevents conformational changes to the virus needed to fuse with host cells,” said senior author Dr. Michael Rossmann, professor of biological sciences at Purdue University.

"There are many antibodies that can neutralize West Nile virus,” said Dr. Rossmann. "These findings concern a specific antibody, called CR4354. It uses an unusual approach to neutralize the virus. Normally an antibody binds to a single molecule, but now we see this cross linking, which is quite clever because it ties everything rigidly together.”

Related Links:
Purdue University




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.